Macrolide antibiotics in the ribosome exit tunnel: species-specific binding and action
- PMID: 22191525
- DOI: 10.1111/j.1749-6632.2011.06315.x
Macrolide antibiotics in the ribosome exit tunnel: species-specific binding and action
Abstract
Macrolide antibiotics bind in the nascent peptide exit tunnel of the ribosome and inhibit protein synthesis. The majority of information on the principles of binding and action of these antibiotics comes from studies that employed model organisms. However, there is a growing understanding that the binding of macrolides to their target, as well as the mode of inhibition of translation, can be strongly influenced by variations in ribosome structure between bacterial species. Awareness of the existence of species-specific differences in drug action and appreciation of the extent of these differences can stimulate future work on developing better macrolide drugs. In this review, representative cases illustrating the organism-specific binding and action of macrolide antibiotics, as well as species-specific mechanisms of resistance are analyzed.
© 2011 New York Academy of Sciences.
Similar articles
-
Interplay between the ribosomal tunnel, nascent chain, and macrolides influences drug inhibition.Chem Biol. 2010 May 28;17(5):504-14. doi: 10.1016/j.chembiol.2010.04.008. Chem Biol. 2010. PMID: 20534348
-
The structure of ribosome-lankacidin complex reveals ribosomal sites for synergistic antibiotics.Proc Natl Acad Sci U S A. 2010 Feb 2;107(5):1983-8. doi: 10.1073/pnas.0914100107. Epub 2010 Jan 11. Proc Natl Acad Sci U S A. 2010. PMID: 20080686 Free PMC article.
-
Species-specific antibiotic-ribosome interactions: implications for drug development.Biol Chem. 2005 Dec;386(12):1239-52. doi: 10.1515/BC.2005.141. Biol Chem. 2005. PMID: 16336118 Review.
-
Macrolide antibiotic interaction and resistance on the bacterial ribosome.Curr Opin Investig Drugs. 2003 Feb;4(2):140-8. Curr Opin Investig Drugs. 2003. PMID: 12669373 Review.
-
On the specificity of antibiotics targeting the large ribosomal subunit.Ann N Y Acad Sci. 2011 Dec;1241:1-16. doi: 10.1111/j.1749-6632.2011.06192.x. Ann N Y Acad Sci. 2011. PMID: 22191523 Review.
Cited by
-
Ribosomal Antibiotics: Contemporary Challenges.Antibiotics (Basel). 2016 Jun 29;5(3):24. doi: 10.3390/antibiotics5030024. Antibiotics (Basel). 2016. PMID: 27367739 Free PMC article. Review.
-
Bacterial Protein Synthesis as a Target for Antibiotic Inhibition.Cold Spring Harb Perspect Med. 2016 Sep 1;6(9):a025361. doi: 10.1101/cshperspect.a025361. Cold Spring Harb Perspect Med. 2016. PMID: 27481773 Free PMC article. Review.
-
Evolution of antibiotic resistance at low antibiotic concentrations including selection below the minimal selective concentration.Commun Biol. 2020 Sep 3;3(1):467. doi: 10.1038/s42003-020-01176-w. Commun Biol. 2020. PMID: 32884065 Free PMC article.
-
Elements of ribosomal drug resistance and specificity.Curr Opin Struct Biol. 2012 Dec;22(6):750-8. doi: 10.1016/j.sbi.2012.07.016. Epub 2012 Sep 13. Curr Opin Struct Biol. 2012. PMID: 22981944 Free PMC article. Review.
-
Antimicrobial Resistance Genes in Bacteria Isolated From Japanese Honey, and Their Potential for Conferring Macrolide and Lincosamide Resistance in the American Foulbrood Pathogen Paenibacillus larvae.Front Microbiol. 2021 Apr 29;12:667096. doi: 10.3389/fmicb.2021.667096. eCollection 2021. Front Microbiol. 2021. PMID: 33995331 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
